The analysis revealed a tendency of downregulation for both proteins (IRS‐2, mean −42%; IGF2BP1, mean −35%) in the NAFLD as compared to non‐NAFLD biopsies. The gene discussed is IGF2BP1; the disease is metabolic dysfunction-associated steatotic liver disease.